Regeneron Pharmaceuticals EYLEA HD Approved by the FDA
Regeneron Pharmaceuticals (REGN) announced that the U.S. FDA has approved EYLEA HD (aflibercept) Injection 8 mg for the treatment of patients with wet age-related macular degeneration (wAMD), diabetic macular edema (DME) and diabetic retinopathy (DR). The recommended dose for EYLEA HD is 8 mg . . .
This content is for paid subscribers.
Today’s Highlights
August 21, 2023
